FDA approves Accord BioPharma's ENNUMO pegfilgrastim biosimilar in the U.S.

The approval adds a second pegfilgrastim option to Accord BioPharma's G-CSF lineup and supports its goal to launch 20 biosimilars in the U.S. by 2030.

17d ago